Immunogenicity of Oral Polio Vaccine and Salk Inactive Polio Vaccine Against Xinjiang Imported Type 1 Wild Poliovirus

An outbreak of an imported Type 1 wild poliovirus from Pakistan occurred in the Xinjiang Uygur Autonomous Region of China in 2011, although the local immunity status of the oral polio vaccine (OPV) was relatively satisfied. Neutralizing antibody titers against the Xinjiang strain and Sabin 1 strain...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Clinical infectious diseases Ročník 70; číslo 9; s. 1980
Hlavní autori: Yan, Dongmei, Wang, Dongyan, Zhu, Shuangli, Zhang, Yong, Li, Xiaolei, Tang, Haishu, Guan, Jing, Xu, Wenbo
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: United States 15.04.2020
Predmet:
ISSN:1537-6591, 1537-6591
On-line prístup:Zistit podrobnosti o prístupe
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract An outbreak of an imported Type 1 wild poliovirus from Pakistan occurred in the Xinjiang Uygur Autonomous Region of China in 2011, although the local immunity status of the oral polio vaccine (OPV) was relatively satisfied. Neutralizing antibody titers against the Xinjiang strain and Sabin 1 strain were measured in 237 sera from 3 groups of fully OPV-vaccinated persons and 1 group of infants fully vaccinated with the inactive polio vaccine (IPV). Additionally, 17 sera collected from 1 Xinjiang poliomyelitis case and his 16 contacts were also tested. Genomic sequencing was conducted the Xinjiang strain. The antibody titers against the Xinjiang strain in each of 237 sera were significantly lower than those against the Sabin 1 strain. Notably, 40.0% of children in Group 1 were seronegative against the Xinjiang strain, which indicated that they might play an important role in wild poliovirus transmission, although their antibody titers against the Sabin 1 strain varied between 1:8 and 1:512. Meanwhile, serological results of the Xinjiang poliomyelitis case and his contacts also provided evidence that a proportion of OPV-vaccinated children had indeed been involved in the transmission chain of the Xinjiang outbreak. Genomic sequencing indicated that the Xinjiang strain was greatly distinguishable from the Sabin 1 strain in neutralizing antigenic sites. The lack of neutralizing antibodies against the Xinjiang strain in persons vaccinated by OPV may be associated with the transmission of Type 1 wild poliovirus in Xinjiang. Using Salk IPV along with OPV might be considered in a wild poliovirus outbreak response, especially in the countries which continued to have persistent wild poliovirus circulation.
AbstractList An outbreak of an imported Type 1 wild poliovirus from Pakistan occurred in the Xinjiang Uygur Autonomous Region of China in 2011, although the local immunity status of the oral polio vaccine (OPV) was relatively satisfied. Neutralizing antibody titers against the Xinjiang strain and Sabin 1 strain were measured in 237 sera from 3 groups of fully OPV-vaccinated persons and 1 group of infants fully vaccinated with the inactive polio vaccine (IPV). Additionally, 17 sera collected from 1 Xinjiang poliomyelitis case and his 16 contacts were also tested. Genomic sequencing was conducted the Xinjiang strain. The antibody titers against the Xinjiang strain in each of 237 sera were significantly lower than those against the Sabin 1 strain. Notably, 40.0% of children in Group 1 were seronegative against the Xinjiang strain, which indicated that they might play an important role in wild poliovirus transmission, although their antibody titers against the Sabin 1 strain varied between 1:8 and 1:512. Meanwhile, serological results of the Xinjiang poliomyelitis case and his contacts also provided evidence that a proportion of OPV-vaccinated children had indeed been involved in the transmission chain of the Xinjiang outbreak. Genomic sequencing indicated that the Xinjiang strain was greatly distinguishable from the Sabin 1 strain in neutralizing antigenic sites. The lack of neutralizing antibodies against the Xinjiang strain in persons vaccinated by OPV may be associated with the transmission of Type 1 wild poliovirus in Xinjiang. Using Salk IPV along with OPV might be considered in a wild poliovirus outbreak response, especially in the countries which continued to have persistent wild poliovirus circulation.
An outbreak of an imported Type 1 wild poliovirus from Pakistan occurred in the Xinjiang Uygur Autonomous Region of China in 2011, although the local immunity status of the oral polio vaccine (OPV) was relatively satisfied.BACKGROUNDAn outbreak of an imported Type 1 wild poliovirus from Pakistan occurred in the Xinjiang Uygur Autonomous Region of China in 2011, although the local immunity status of the oral polio vaccine (OPV) was relatively satisfied.Neutralizing antibody titers against the Xinjiang strain and Sabin 1 strain were measured in 237 sera from 3 groups of fully OPV-vaccinated persons and 1 group of infants fully vaccinated with the inactive polio vaccine (IPV). Additionally, 17 sera collected from 1 Xinjiang poliomyelitis case and his 16 contacts were also tested. Genomic sequencing was conducted the Xinjiang strain.METHODSNeutralizing antibody titers against the Xinjiang strain and Sabin 1 strain were measured in 237 sera from 3 groups of fully OPV-vaccinated persons and 1 group of infants fully vaccinated with the inactive polio vaccine (IPV). Additionally, 17 sera collected from 1 Xinjiang poliomyelitis case and his 16 contacts were also tested. Genomic sequencing was conducted the Xinjiang strain.The antibody titers against the Xinjiang strain in each of 237 sera were significantly lower than those against the Sabin 1 strain. Notably, 40.0% of children in Group 1 were seronegative against the Xinjiang strain, which indicated that they might play an important role in wild poliovirus transmission, although their antibody titers against the Sabin 1 strain varied between 1:8 and 1:512. Meanwhile, serological results of the Xinjiang poliomyelitis case and his contacts also provided evidence that a proportion of OPV-vaccinated children had indeed been involved in the transmission chain of the Xinjiang outbreak. Genomic sequencing indicated that the Xinjiang strain was greatly distinguishable from the Sabin 1 strain in neutralizing antigenic sites.RESULTSThe antibody titers against the Xinjiang strain in each of 237 sera were significantly lower than those against the Sabin 1 strain. Notably, 40.0% of children in Group 1 were seronegative against the Xinjiang strain, which indicated that they might play an important role in wild poliovirus transmission, although their antibody titers against the Sabin 1 strain varied between 1:8 and 1:512. Meanwhile, serological results of the Xinjiang poliomyelitis case and his contacts also provided evidence that a proportion of OPV-vaccinated children had indeed been involved in the transmission chain of the Xinjiang outbreak. Genomic sequencing indicated that the Xinjiang strain was greatly distinguishable from the Sabin 1 strain in neutralizing antigenic sites.The lack of neutralizing antibodies against the Xinjiang strain in persons vaccinated by OPV may be associated with the transmission of Type 1 wild poliovirus in Xinjiang. Using Salk IPV along with OPV might be considered in a wild poliovirus outbreak response, especially in the countries which continued to have persistent wild poliovirus circulation.CONCLUSIONThe lack of neutralizing antibodies against the Xinjiang strain in persons vaccinated by OPV may be associated with the transmission of Type 1 wild poliovirus in Xinjiang. Using Salk IPV along with OPV might be considered in a wild poliovirus outbreak response, especially in the countries which continued to have persistent wild poliovirus circulation.
Author Yan, Dongmei
Tang, Haishu
Guan, Jing
Li, Xiaolei
Wang, Dongyan
Xu, Wenbo
Zhu, Shuangli
Zhang, Yong
Author_xml – sequence: 1
  givenname: Dongmei
  surname: Yan
  fullname: Yan, Dongmei
  organization: National Health Commission Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing
– sequence: 2
  givenname: Dongyan
  surname: Wang
  fullname: Wang, Dongyan
  organization: Regional Reference Poliomyelitis Laboratory, World Health Organization Western Pacific Regional Office, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing
– sequence: 3
  givenname: Shuangli
  surname: Zhu
  fullname: Zhu, Shuangli
  organization: Regional Reference Poliomyelitis Laboratory, World Health Organization Western Pacific Regional Office, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing
– sequence: 4
  givenname: Yong
  surname: Zhang
  fullname: Zhang, Yong
  organization: Xinjiang Uyghur Autonomous Region Center for Disease Control and Prevention, Urumqi, People's Republic of China
– sequence: 5
  givenname: Xiaolei
  surname: Li
  fullname: Li, Xiaolei
  organization: Regional Reference Poliomyelitis Laboratory, World Health Organization Western Pacific Regional Office, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing
– sequence: 6
  givenname: Haishu
  surname: Tang
  fullname: Tang, Haishu
  organization: Xinjiang Uyghur Autonomous Region Center for Disease Control and Prevention, Urumqi, People's Republic of China
– sequence: 7
  givenname: Jing
  surname: Guan
  fullname: Guan, Jing
  organization: National Health Commission Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing
– sequence: 8
  givenname: Wenbo
  surname: Xu
  fullname: Xu, Wenbo
  organization: National Health Commission Key Laboratory of Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31240315$$D View this record in MEDLINE/PubMed
BookMark eNpdUElLAzEYDVKxi178AZKjl9Fssx1LcRkoKFiX25BJvpTUmWSczBTqr7fQCuLh8R685fCmaOS8A4QuKbmhJOe3yuo9vmORn6AJjXkaJXFOR3_0GE1D2BBCaUbiMzTmlAnCaTxBQ9E0g_NrcFbZfoe9wU-drPGzr63Hb1Ip6wBLp_GLrD9x4aTq7Rb--fO1tC70-MO6jZVujYum9V0PGq92LWCK322tD52t7YZwjk6NrANcHHmGXu_vVovHaPn0UCzmy0jxmPdRJSBJM5lyZRJmGJcEwEAl8kRVWcaMztJKCzBG5DGlVAtamZxV1DAQKss5m6Hrw27b-a8BQl82Niioa-nAD6FkXBAiOBFiH706RoeqAV22nW1ktyt_r2I_prNtrg
CitedBy_id crossref_primary_10_1093_infdis_jiaa386
crossref_primary_10_1128_spectrum_01334_25
ContentType Journal Article
Copyright The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Copyright_xml – notice: The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1093/cid/ciz549
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1537-6591
ExternalDocumentID 31240315
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations China
Pakistan
GeographicLocations_xml – name: China
– name: Pakistan
GroupedDBID ---
..I
.2P
.I3
.ZR
08P
0R~
29B
2WC
36B
4.4
48X
53G
5GY
5RE
5VS
5WD
6J9
70D
AABZA
AACGO
AACZT
AAJKP
AAMVS
AANCE
AAOGV
AAPNW
AAPQZ
AAPXW
AAQQT
AARHZ
AAUAY
AAUQX
AAVAP
ABDFA
ABEJV
ABEUO
ABGNP
ABIXL
ABJNI
ABKDP
ABLJU
ABNHQ
ABNKS
ABOCM
ABPLY
ABPTD
ABQLI
ABQNK
ABTLG
ABVGC
ABWST
ABXVV
ABZBJ
ACGFO
ACGFS
ACPRK
ACUFI
ACUTJ
ACUTO
ACYHN
ADBBV
ADEYI
ADGZP
ADHKW
ADHZD
ADIPN
ADJQC
ADOCK
ADQBN
ADRIX
ADRTK
ADVEK
ADYVW
ADZXQ
AEGPL
AEGXH
AEJOX
AEKSI
AEMDU
AENEX
AENZO
AEPUE
AETBJ
AEUPB
AEWNT
AFFZL
AFIYH
AFOFC
AFRAH
AFXAL
AFXEN
AGINJ
AGKEF
AGQXC
AGSYK
AGUTN
AHMBA
AHMMS
AHXPO
AIAGR
AIJHB
AJEEA
ALMA_UNASSIGNED_HOLDINGS
ALUQC
APIBT
APWMN
AQKUS
ATGXG
AXUDD
BAWUL
BAYMD
BCRHZ
BEYMZ
BHONS
BTRTY
BVRKM
C45
CDBKE
CGR
CS3
CUY
CVF
CZ4
DAKXR
DIK
DILTD
DU5
D~K
E3Z
EBS
ECM
EE~
EIF
EMOBN
ENERS
ESX
F5P
F9B
FECEO
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
H13
H5~
HAR
HW0
HZ~
IOX
J21
JLS
JSG
KAQDR
KBUDW
KOP
KSI
KSN
L7B
M49
MHKGH
MJL
ML0
N9A
NGC
NOMLY
NOYVH
NPM
NU-
O9-
OAUYM
OAWHX
OCZFY
ODMLO
ODZKP
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
P2P
P6G
PAFKI
PEELM
PQQKQ
Q1.
Q5Y
RD5
ROX
ROZ
RUSNO
RW1
RXO
SJN
TCURE
TEORI
TJX
TMA
TR2
W8F
X7H
YAYTL
YKOAZ
YXANX
~91
~S-
7X8
ABPQP
ADNBA
AEMQT
AFYAG
AHGBF
AJBYB
AJNCP
ALXQX
JXSIZ
ID FETCH-LOGICAL-c353t-b4e678a73cf62f23a0eefeb496cb882fd87bd4eff495111d41bf92b1f2e4c8932
IEDL.DBID 7X8
ISICitedReferencesCount 3
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000537513500027&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1537-6591
IngestDate Sun Sep 28 07:44:05 EDT 2025
Wed Feb 19 02:30:01 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords Type 1 wild poliovirus
oral polio vaccine
neutralizing antibody
Language English
License The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c353t-b4e678a73cf62f23a0eefeb496cb882fd87bd4eff495111d41bf92b1f2e4c8932
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://academic.oup.com/cid/article-pdf/70/9/1980/33045487/ciz549.pdf
PMID 31240315
PQID 2340043044
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2340043044
pubmed_primary_31240315
PublicationCentury 2000
PublicationDate 2020-04-15
PublicationDateYYYYMMDD 2020-04-15
PublicationDate_xml – month: 04
  year: 2020
  text: 2020-04-15
  day: 15
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Clinical infectious diseases
PublicationTitleAlternate Clin Infect Dis
PublicationYear 2020
SSID ssj0011805
Score 2.3422563
Snippet An outbreak of an imported Type 1 wild poliovirus from Pakistan occurred in the Xinjiang Uygur Autonomous Region of China in 2011, although the local immunity...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 1980
SubjectTerms Child
China - epidemiology
Humans
Infant
Pakistan
Poliomyelitis - epidemiology
Poliomyelitis - prevention & control
Poliovirus - genetics
Poliovirus Vaccine, Inactivated
Poliovirus Vaccine, Oral
Title Immunogenicity of Oral Polio Vaccine and Salk Inactive Polio Vaccine Against Xinjiang Imported Type 1 Wild Poliovirus
URI https://www.ncbi.nlm.nih.gov/pubmed/31240315
https://www.proquest.com/docview/2340043044
Volume 70
WOSCitedRecordID wos000537513500027&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1JS8NAFB7cEC_uS90YwWtoZ8s0JylisQer4EJvZfJmpsQl0S6C_nrfpCmCBxG85JDkQZj55s335r18j5BTJbhPHPdRQ3vAAEWqKIl1HKWegY5BWKXSstmE7nabvV5yUx24jaqyyplPLB21LSCckde5kKU-lZRnr29R6BoVsqtVC415siiQygRU6953FoE1yxJGXNQ6ilXCZvKkiagDTjVkn0r-Qi3LLaa99t-PWyerFbmkrSkaNsicyzfJ8lWVPt8ik074G6RAzOCN8QctPL0eokEogivog4HwGjW5pbfm-Yl2clN6wx_PWwOTIamkvSx_RHANaOelVEe3NAS1lFH0NHZq854NJ6Ntct--uDu_jKq-CxEIJcZRKh1uYUYL8DH3XJiGc96lMokhRULubVOnVjrvMbhCV2klS33CU-a5k4D8h--QhbzI3R6hIjFOOiuV8hiKGLQExsBKC8ABnK6Rk9mA9hHXIVlhcldMRv3vIa2R3ems9F-nAhx9wYKKIFP7f7A-ICs8hMhBnlEdkkWPq9odkSV4H2ej4XEJGLx2b66-AJYHzTk
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Immunogenicity+of+Oral+Polio+Vaccine+and+Salk+Inactive+Polio+Vaccine+Against+Xinjiang+Imported+Type+1+Wild+Poliovirus&rft.jtitle=Clinical+infectious+diseases&rft.au=Yan%2C+Dongmei&rft.au=Wang%2C+Dongyan&rft.au=Zhu%2C+Shuangli&rft.au=Zhang%2C+Yong&rft.date=2020-04-15&rft.issn=1537-6591&rft.eissn=1537-6591&rft.volume=70&rft.issue=9&rft.spage=1980&rft_id=info:doi/10.1093%2Fcid%2Fciz549&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1537-6591&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1537-6591&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1537-6591&client=summon